Artificial Heartlung Machine Market Report
Published Date: 22 April 2026 | Report Code: artificial-heartlung-machine
Artificial Heartlung Machine Market Size, Share, Industry Trends and Forecast to 2033
This report provides an in-depth analysis of the Artificial Heartlung Machine market, highlighting insights on market size, growth forecasts, and industry trends for the period 2023 to 2033.
Key Takeaways
- Market value moves from $5.70 Billion in 2023 to $11.65 Billion by 2033, reflecting a 7.2% CAGR over the forecast period.
- North America is both the largest and the fastest-growing market, rising from $1.97 Billion in 2023 to $4.03 Billion in 2033.
- Europe and Asia Pacific are substantial regional contributors: Europe increases from $1.62 Billion to $3.31 Billion, Asia Pacific from $1.09 Billion to $2.23 Billion.
- Middle East and Africa and Latin America display steady expansion: MEA grows from $0.7 Billion to $1.43 Billion; Latin America from $0.32 Billion to $0.65 Billion.
- Leading vendors include Medtronic, Abbott Laboratories, Terumo Corporation, Getinge AB, and Sorin Group, emphasizing competitive R&D activity.
Artificial Heartlung Machine Market Report — Executive Summary
This report examines the Artificial Heartlung Machine market across the 2023 to 2033 forecast window, documenting a market size of $5.70 Billion in 2023 and a rise to $11.65 Billion by 2033 at a 7.2% CAGR. Expansion is driven by technological improvements, rising clinical adoption in hospitals, and focused R&D from major suppliers such as Medtronic and Abbott Laboratories. Regional performance is led by North America as both the largest and fastest-growing market, while Europe and Asia Pacific register meaningful gains. The analysis covers product categories including invasive and non-invasive devices plus consumables, end users spanning hospitals to research institutes, and applications from cardiac surgery to respiratory failure. Competitive profiling highlights product strategies and partnerships among top participants. The research synthesizes primary interviews and secondary sources to deliver validated market estimates and trend insight for stakeholders planning investment, product development, or market entry.
Key Growth Drivers
- Advances in device design and functionality that enhance perioperative cardiopulmonary support and clinical outcomes.
- Rising procedural volumes and increased adoption of extracorporeal support in hospitals and surgical centers.
- Sustained investment and R&D activity by incumbent firms such as Medtronic and Terumo Corporation.
- Regional healthcare infrastructure growth and improved access to advanced cardiac care in emerging markets.
- Greater focus on patient safety and monitoring capabilities prompting upgrades and purchases of newer systems.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.70 Billion |
| CAGR (2023-2033) | 7.2% |
| 2033 Market Size | $11.65 Billion |
| Top Companies | Medtronic , Abbott Laboratories, Terumo Corporation, Getinge AB, Sorin Group |
| Last Modified Date | 22 April 2026 |
Artificial Heartlung Machine Market Overview
Customize Artificial Heartlung Machine Market Report market research report
- ✔ Get in-depth analysis of Artificial Heartlung Machine market size, growth, and forecasts.
- ✔ Understand Artificial Heartlung Machine's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Artificial Heartlung Machine
What is the Market Size & CAGR of Artificial Heartlung Machine Market Report market in 2023?
Artificial Heartlung Machine Industry Analysis
Artificial Heartlung Machine Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Artificial Heartlung Machine Market Report Market Analysis Report by Region
Europe Artificial Heartlung Machine Market Report:
Europe grows from $1.62 Billion in 2023 to $3.31 Billion in 2033. Growth reflects upgrades in surgical infrastructure, technology adoption, and demand for both devices and consumables across hospitals and specialized centers.Asia Pacific Artificial Heartlung Machine Market Report:
Asia Pacific expands from $1.09 Billion in 2023 to $2.23 Billion in 2033. Rise in procedure volumes, expanding healthcare access, and increased procurement of modern support systems underpin regional market gains.North America Artificial Heartlung Machine Market Report:
North America is the largest and fastest-growing region, rising from $1.97 Billion in 2023 to $4.03 Billion in 2033. Regional expansion is propelled by high clinical adoption in hospitals, established vendor presence, and investment in advanced cardiothoracic care.South America Artificial Heartlung Machine Market Report:
Middle East & Africa Artificial Heartlung Machine Market Report:
Middle East and Africa advances from $0.7 Billion in 2023 to $1.43 Billion in 2033. Market growth is supported by improving hospital capabilities and increased focus on critical care equipment procurement.Tell us your focus area and get a customized research report.
Research Methodology
Artificial Heartlung Machine Market Analysis By Product
In 2023, the Invasive Devices segment dominates the market with a size of $3.45 billion and retains a share of 60.5%. This dominance is attributed to the necessity of invasive procedures in critical care scenarios. The Non-Invasive Devices segment, valued at $1.57 billion (27.62% share), and Consumables at $0.68 billion (11.88% share) are also significant contributors, representing their growing importance in patient care and operational efficiency.
Artificial Heartlung Machine Market Analysis By Application
The market by application includes key segments such as Cardiac Surgery, which dominates with a size of $2.45 billion (42.97% share) in 2023, followed by Respiratory Failure and Heart Transplantation, valued at $1.27 billion (22.25%) and $0.75 billion (13.1%), respectively. The growth in these applications is driven by advancements in surgical techniques and a growing number of patients requiring heart and lung interventions.
Artificial Heartlung Machine Market Analysis By End User
Hospitals represent the largest segment by end-user, valued at $3.29 billion (57.76% share) in 2023, emphasizing their critical role in healthcare. Ambulatory Surgery Centers and Urgent Care Centers also contribute significantly, valued at $1.40 billion (24.61%) and $0.55 billion (9.58%), respectively, driven by the increasing prevalence of outpatient surgeries and urgent medical needs.
Artificial Heartlung Machine Market Analysis By Region
Regional analysis underscores North America's leadership in market size and growth potential. Europe follows closely with advancements in healthcare infrastructure and patient care. The Asia-Pacific region exhibits rapid growth due to rising healthcare access, while South America and the Middle East & Africa are poised for incremental expansion fueled by healthcare improvements and increased investments.
Artificial Heartlung Machine Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Artificial Heartlung Machine Industry
Medtronic :
A leading global supplier of healthcare solutions, known for innovations in cardiac devices including heartlung machines and related technology.Abbott Laboratories:
A prominent healthcare manufacturer with a focus on cardiovascular devices, contributing significantly to the development of advanced heartlung support systems.Terumo Corporation:
A diversified medical device manufacturer that focuses on innovations in heart-lung machines and cardiopulmonary support technologies.Getinge AB:
A global leader in providing advanced solutions for healthcare, particularly in critical care and surgical applications involving artificial heart and lung machines.Sorin Group:
Specialized in cardiac surgery products, including blood management devices and heartlung machines that enhance surgical procedures and patient outcomes.We're grateful to work with incredible clients.
FAQs
What is the market size of the Artificial Heartlung Machine Market Report in 2023?
The reported market size for 2023 is $5.70 Billion. The forecast covers 2023 to 2033 and includes a projected market value of $11.65 Billion by 2033 at a 7.2% CAGR.
How big will the market be in 2033?
The market is projected to reach $11.65 Billion in 2033. This projection is tied to an anticipated compound annual growth rate of 7.2% during the 2023 to 2033 forecast period.
What is CAGR of the Artificial Heartlung Machine Market Report?
The compound annual growth rate specified for the 2023 to 2033 timeframe is 7.2%. That rate underpins movement from $5.70 Billion in 2023 to $11.65 Billion in 2033.
Why is North America significant in this market?
North America is both the largest and fastest-growing region, increasing from $1.97 Billion in 2023 to $4.03 Billion in 2033, driven by high hospital adoption and vendor activity.
Which regions show notable growth between 2023 and 2033?
Europe rises from $1.62 Billion to $3.31 Billion and Asia Pacific from $1.09 Billion to $2.23 Billion, reflecting expanded clinical use and healthcare investments in those regions.
Who are the top companies operating in the market?
Top listed companies include Medtronic, Abbott Laboratories, Terumo Corporation, Getinge AB, and Sorin Group, which influence product development and competitive dynamics across regions.
What end users drive demand for heartlung machines?
Primary end users include hospitals, ambulatory surgery centers, urgent care centers, and research institutes, each contributing to equipment procurement and consumables usage patterns.
How big is the Latin America market in the forecast?
Latin America is reported at $0.32 Billion in 2023 and is projected to reach $0.65 Billion by 2033, reflecting gradual adoption and regional healthcare capacity expansion.
What factors support market expansion through 2033?
Expansion is supported by technological improvements, increased surgical volumes, and investments from major suppliers, which together contribute to the 7.2% CAGR through 2033.
What is the market outlook for Middle East and Africa?
Middle East and Africa is shown at $0.7 Billion in 2023, growing to $1.43 Billion in 2033, indicating increasing procurement as regional healthcare services mature.